JPRN-C000000202已完成4 期
Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitis - GLSG, 2004, ARB
Gunma Liver Study Group0 个研究点目标入组 10 人开始时间: 2005年9月13日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Allergy to Angiotensin II receptor Antagonist(ARB) complication with liver diseases due to other causes secondary NASH medication history of ARB or ACE inhibitors
研究者
相似试验
已完成
不适用
Evaluation of the effect of AngiotensinII receptor blocker on coronary artery after Sirolimus-Eluting Stent implantatioJPRN-UMIN000001822Toyohashi Heart Ceter, Cardiovascular Medicine50
已完成
不适用
Effectiveness of angiotensin II receptor blocker for postoperative atrial fibrillation in patients with open heart surgerypatients of open heart surgery with hypertentionJPRN-UMIN000005377Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine120
已完成
不适用
Impact of angiotensin II receptor antagoniston on adriamycin-induced cardiomyopathyMarignancy patients who will treat with adriamycinJPRN-UMIN000005066Division of Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine100
已完成
不适用
The effects of angiotensin II receptor blockade on renal blood flow in atherosclerotic kidney diseasechronic kidney diseaseJPRN-UMIN000021355Keio University, School of Medicine40
已完成
不适用
Supplemental Benefit of Angiotensin II Receptor Blocker in Hypertensive Patients with Stable Heart Failure using OlmesartaChronic Heart FailureJPRN-UMIN000000561Tohoku Heart Failure Association The SUPPORT Study Group1,000